Department of Prosthodontics, (Head: Dr. Liselott Lindh, DDS, PhD), Faculty of Odontology, Malmö University, Carl Gustafs väg 34, SE-21421, Malmö, Sweden.
J Craniomaxillofac Surg. 2018 Aug;46(8):1211-1217. doi: 10.1016/j.jcms.2018.05.038. Epub 2018 May 21.
PURPOSE: This study sought to assess the clinical outcome and survival rate of oral implants placed in individuals with ectodermal dysplasia (ED), based on previously published studies. METHODS: An electronic search without time restrictions was undertaken in 5 databases (PubMed/Medline, Web of Science, ScienceDirect, J-Stage, Lilacs). Descriptive statistics, Kaplan Meier estimator and implant failure probability were calculated. RESULTS: 90 publications were included, reporting 228 ED patients that received 1472 implants (1392 conventional, 47 zygomatic, 33 mini-implants). Mean age of the patients was 20.2 ± 6.8 years (2-56). Patients had a mean of 3.2 ± 2.5 maxillary and 2.1 ± 2.6 mandibular permanent teeth (min-max, 0-14). Patients received a mean of 8.2 ± 3.8 implants (1-20). Most implants were placed in the third decade of life, 24.6% of the implants were placed in children (0-17 years of age). 1391 implants had information on follow-up (72 failures, 5.2%). The 20-year CSR was 84.6%. The probability of failure was 4.5% (95%CI 3.5%-5.6%, p < 0.001). Additional treatments performed were Le Fort I (99 implants, 20 patients, 3.5% failed), grafting (497 implants, 77 patients, 5.2% failed), distraction osteogenesis (79 implants, 16 patients, 10.1% failed). Mean follow-up was 42.9 ± 41.9 months (min-max, 2-240). CONCLUSIONS: Dental implants placed in ED patients, either infants or adults, present a high survival rate (20-year CSR 84.6%).
目的:本研究旨在评估基于先前发表的研究,将口腔种植体植入外胚层发育不全(ED)患者的临床结果和存活率。
方法:无时间限制地在 5 个数据库(PubMed/Medline、Web of Science、ScienceDirect、J-Stage、Lilacs)中进行电子检索。计算描述性统计、Kaplan-Meier 估计器和种植体失败概率。
结果:共纳入 90 篇文献,报道了 228 例 ED 患者接受了 1472 枚种植体(1392 枚常规种植体、47 枚颧骨种植体、33 枚迷你种植体)。患者的平均年龄为 20.2±6.8 岁(2-56 岁)。患者平均有 3.2±2.5 颗上颌永久牙和 2.1±2.6 颗下颌永久牙(最小-最大,0-14 颗)。患者平均植入 8.2±3.8 枚种植体(1-20 枚)。大多数种植体在第三十年植入,24.6%的种植体在儿童(0-17 岁)中植入。1391 个种植体有随访信息(72 个失败,5.2%)。20 年 CSR 为 84.6%。失败概率为 4.5%(95%CI 3.5%-5.6%,p<0.001)。另外进行的治疗包括 Le Fort I(99 个种植体,20 个患者,3.5%失败)、植骨(497 个种植体,77 个患者,5.2%失败)、牵引成骨(79 个种植体,16 个患者,10.1%失败)。平均随访时间为 42.9±41.9 个月(最小-最大,2-240 个月)。
结论:植入 ED 患者(婴儿或成人)的牙种植体具有很高的存活率(20 年 CSR 为 84.6%)。
J Craniomaxillofac Surg. 2018-5-21
Int J Oral Maxillofac Surg. 2016-8
Int J Paediatr Dent. 2005-7
J Prosthet Dent. 2002-7
Int J Oral Maxillofac Implants. 2001
Natl J Maxillofac Surg. 2025
Clin Cosmet Investig Dent. 2023-8-7
Medicina (Kaunas). 2021-12-27
Materials (Basel). 2021-12-20
Int J Environ Res Public Health. 2020-12-28